ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company has received a Notice of Allowance from the U.S.
Medscape3d
Gastric Bypass Beats Sleeve Gastrectomy in the Long Run
Roux-en-Y gastric bypass led to greater weight loss than sleeve gastrectomy in patients with obesity at 10 years, according ...
rnz20d
Kiwis return from overseas weight loss surgery with life-threatening complications
At a cost of $29,000 to go private, a gastric bypass or gastric sleeve was out of reach for many who were turning to Mexico, Thailand and Turkey for operations as cheap as $8000. One Waikato woman - ...